Rivoceranib Appears Active in Recurrent, Metastatic Adenoid Cystic Carcinoma
Rivoceranib produced responses whether or not patients had received prior treatment with a VEGFR TKI.
Rivoceranib produced responses whether or not patients had received prior treatment with a VEGFR TKI.
Avasopasem manganese provided a clinically meaningful benefit to patients who developed treatment-related severe oral mucositis.
Researchers conducted a randomized study to evaluate docetaxel as a radiosensitizer in patients with LAHNSCC who are cisplatin-ineligible.
Weekly cisplatin plus radiotherapy should be considered standard care in locally advanced head and neck squamous cell carcinoma, according to researchers.
Adding nimotuzumab to concomitant chemoradiotherapy may improve 5-year survival in locally advanced nasopharyngeal carcinoma.
Higher doses of gabapentin are associated with delayed time to first opioid use.
In a Dutch study, each doubling of urine albumin excretion was significantly associated with a 7% increase in overall cancer risk.
The use of proton beam therapy (PBT) increased between 2004 and 2018, particularly for cancers in which the effectiveness of PBT is still under investigation.
The risk of neurologic adverse events was 41% lower in patients treated with immune checkpoint inhibitors than in patients who received another drug regimen or a placebo.
A high neutrophil-lymphocyte ratio appears to be an independent predictor of outcomes for some patients with head and neck cancer.